Serveur d'exploration sur la glutarédoxine - Exploration (Accueil)

Index « Titre (en) » - entrée « implications »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
implication < implications < import  Facettes :

List of bibliographic references indexed by implications

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000150 (2019) Deepika Das [États-Unis] ; Shachin Patra [États-Unis] ; Jennifer Bridwell-Rabb [États-Unis] ; David P. Barondeau [États-Unis]Mechanism of frataxin "bypass" in human iron-sulfur cluster biosynthesis with implications for Friedreich's ataxia.
000182 (2019) Olga Gorelenkova Miller [États-Unis] ; John J. Mieyal [États-Unis]Critical Roles of Glutaredoxin in Brain Cells-Implications for Parkinson's Disease.
000367 (2017) Tyler J. Bechtel [États-Unis] ; Eranthie Weerapana [États-Unis]From structure to redox: The diverse functional roles of disulfides and implications in disease.
000400 (2016) Olga Gorelenkova Miller [États-Unis] ; Jessica Belle Behring [États-Unis] ; Sandra L. Siedlak [États-Unis] ; Sirui Jiang [États-Unis] ; Reiko Matsui [États-Unis] ; Markus M. Bachschmid [États-Unis] ; Xiongwei Zhu [États-Unis] ; John J. Mieyal [États-Unis]Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
000426 (2016) William M. Johnson ; Marcin Golczak ; Kyonghwan Choe ; Pierce L. Curran ; Olga Gorelenkova Miller ; Chen Yao ; Wenzhang Wang ; Jiusheng Lin [États-Unis] ; Nicole M. Milkovic [États-Unis] ; Ajit Ray [Inde] ; Vijayalakshmi Ravindranath [Inde] ; Xiongwei Zhu ; Mark A. Wilson [États-Unis] ; Amy L. Wilson-Delfosse ; Shu G. Chen ; John J. Mieyal [États-Unis]Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease.
000502 (2015) Lefentse N. Mashamaite [Afrique du Sud] ; Johann M. Rohwer [Afrique du Sud] ; Ché S. Pillay [Afrique du Sud]The glutaredoxin mono- and di-thiol mechanisms for deglutathionylation are functionally equivalent: implications for redox systems biology.
000582 (2014) Jie Li [États-Unis] ; Donglan Zhang [États-Unis] ; Pearl A. Jefferson [États-Unis] ; Kathleen M. Ward [États-Unis] ; Iraimoudi S. Ayene [États-Unis]A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds.
000611 (2014) Michael J. Hitchler [États-Unis] ; Frederick E. DomannRegulation of CuZnSOD and its redox signaling potential: implications for amyotrophic lateral sclerosis.
000670 (2014) Faraz Ahmad [Inde] ; Prakash Nidadavolu [Inde] ; Lalitha Durgadoss [Inde] ; Vijayalakshmi Ravindranath [Inde]Critical cysteines in Akt1 regulate its activity and proteasomal degradation: implications for neurodegenerative diseases.
000682 (2014) Ver Nica Casa As-Sánchez [Espagne] ; José A. Pérez ; Noemí Fabelo ; Antonio V. Herrera-Herrera ; Cecilia Fernández ; Raquel Marín ; María C. González-Montelongo ; Mario DíazAddition of docosahexaenoic acid, but not arachidonic acid, activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: potential implications in neuroprotection.
000735 (2013) Bo Zhang [États-Unis] ; Sibali Bandyopadhyay ; Priyanka Shakamuri ; Sunil G. Naik ; Boi Hanh Huynh ; Jérémy Couturier ; Nicolas Rouhier ; Michael K. JohnsonMonothiol glutaredoxins can bind linear [Fe3S4]+ and [Fe4S4]2+ clusters in addition to [Fe2S2]2+ clusters: spectroscopic characterization and functional implications.
000781 (2013) Grace Choong [Canada] ; Ying Liu ; Weiqun Xiao ; Douglas M. TempletonCadmium-induced glutathionylation of actin occurs through a ROS-independent mechanism: implications for cytoskeletal integrity.
000788 (2013) Xing-Huang Gao [États-Unis] ; Suparna Qanungo [États-Unis] ; Harish V. Pai [États-Unis] ; David W. Starke [États-Unis] ; Kelly M. Steller [États-Unis] ; Hisashi Fujioka [États-Unis] ; Edward J. Lesnefsky [États-Unis] ; Janos Kerner [États-Unis] ; Mariana G. Rosca [États-Unis] ; Charles L. Hoppel [États-Unis] ; John J. Mieyal [États-Unis]Aging-dependent changes in rat heart mitochondrial glutaredoxins--Implications for redox regulation.
000938 (2011) Elizabeth A Sabens Liedhegner [États-Unis] ; Kelly M. Steller ; John J. MieyalLevodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.
000A18 (2010) Elizabeth A. Sabens [États-Unis] ; Anne M. Distler ; John J. MieyalLevodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.
000A26 (2010) Molly M. Gallogly [États-Unis] ; Melissa D. Shelton ; Suparna Qanungo ; Harish V. Pai ; David W. Starke ; Charles L. Hoppel ; Edward J. Lesnefsky ; John J. MieyalGlutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: implications for cardiac aging.
000A81 (2009) Rui Bao [République populaire de Chine] ; Yaru Zhang ; Xiaochu Lou ; Cong-Zhao Zhou ; Yuxing ChenStructural and kinetic analysis of Saccharomyces cerevisiae thioredoxin Trx1: implications for the catalytic mechanism of GSSG reduced by the thioredoxin system.
000B55 (2009) Donna W. Lee [États-Unis] ; Deepinder Kaur ; Shankar J. Chinta ; Subramanian Rajagopalan ; Julie K. AndersenA disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.
000B91 (2008) John J. Mieyal [États-Unis] ; Molly M. Gallogly ; Suparna Qanungo ; Elizabeth A. Sabens ; Melissa D. SheltonMolecular mechanisms and clinical implications of reversible protein S-glutathionylation.
000B94 (2008) Molly M. Gallogly [États-Unis] ; David W. Starke ; Amanda K. Leonberg ; Susan M English Ospina ; John J. MieyalKinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles.
000C43 (2007) Carsten Berndt [Suède] ; Christopher Horst Lillig ; Arne HolmgrenThiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "implications" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "implications" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    implications
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020